Ch. 3, § 7. Consultation Process

(a) After the Department receives a completed client information packet, the Department will review the submitted information. Based on the submitted information, the Department will then make the determination if a consultation is warranted. The Department reserves the right to determine if the client is eligible. (b) The Department will refer the client information to a participating pharmacist. (c) The pharmacist will: (i) Review all client information provided by the client and, at a minimum, analyze it for possible drug interactions, therapeutic duplications, and possible cost saving alternatives. (ii) Conduct a thorough consultation with the client, including a comprehensive interview of current health practices and an in-depth review of all medications. (iii) Provide written recommendations to the client and health care team regarding the patient's current use of medications. (iv) Refer qualifying clients to applicable drug manufacturer assistance programs. (v) Provide to the Department, in a timely manner, a copy of client recommendations, including estimated monthly medication cost savings. When possible, provide the Department with a summary of cost savings resulting from serious side effect or contraindication discoveries in the analysis. (vi) Obtain drug manufacturer patient assistance forms for clients when indicated. (vii) Assist the client in completing the patient assistance forms in order for client to transfer them to his/her prescribing provider for signature.